1. Maximum likelihood pandemic-scale phylogenetics
- Author
-
Nicola De Maio, Prabhav Kalaghatgi, Yatish Turakhia, Russell Corbett-Detig, Bui Quang Minh, and Nick Goldman
- Subjects
Likelihood Functions ,SARS-CoV-2 ,Prevention ,Human Genome ,COVID-19 ,Bayes Theorem ,Biological Sciences ,Medical and Health Sciences ,Article ,Emerging Infectious Diseases ,Good Health and Well Being ,2.5 Research design and methodologies (aetiology) ,Pneumonia & Influenza ,Genetics ,Humans ,Aetiology ,Infection ,Pandemics ,Phylogeny ,Developmental Biology - Abstract
SummaryPhylogenetics plays a crucial role in the interpretation of genomic data1. Phylogenetic analyses of SARS-CoV-2 genomes have allowed the detailed study of the virus’s origins2, of its international3,4 and local4–9 spread, and of the emergence10 and reproductive success11 of new variants, among many applications. These analyses have been enabled by the unparalleled volumes of genome sequence data generated and employed to study and help contain the pandemic12. However, preferred model-based phylogenetic approaches including maximum likelihood and Bayesian methods, mostly based on Felsenstein’s ‘pruning’ algorithm13,14, cannot scale to the size of the datasets from the current pandemic4,15, hampering our understanding of the virus’s evolution and transmission16. We present new approaches, based on reworking Felsenstein’s algorithm, for likelihood-based phylogenetic analysis of epidemiological genomic datasets at unprecedented scales. We exploit near-certainty regarding ancestral genomes, and the similarities between closely related and densely sampled genomes, to greatly reduce computational demands for memory and time. Combined with new methods for searching amongst candidate evolutionary trees, this results in our MAPLE (‘MAximum Parsimonious Likelihood Estimation’) software giving better results than popular approaches such as FastTree 217, IQ-TREE 218, RAxML-NG19 and UShER15. Our approach therefore allows complex and accurate proba-bilistic phylogenetic analyses of millions of microbial genomes, extending the reach of genomic epidemiology. Future epidemiological datasets are likely to be even larger than those currently associated with COVID-19, and other disciplines such as metagenomics and biodiversity science are also generating huge numbers of genome sequences20–22. Our methods will permit continued use of preferred likelihood-based phylogenetic analyses.
- Published
- 2022